Cullinan Therapeutics, Inc. (CGEM) at a glance

Cullinan Therapeutics, Inc. (CGEM) is a small-cap Healthcare company. It trades at $21.77, with a P/E of 9 and a 0% profit margin. It does not pay a dividend. Vestovix scores it 69/100 overall. Its strongest dimension is Safety (96/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$21.77

Market cap

$842.0M

P/E ratio

9.0

Dividend yield

None

Beta

0.01

52-week range

$5.68 to $23.19